First-in-class pan-KRAS inhibitor shows strong antitumor activity in preclinical models

Retrieved on: 2025-09-03 19:15:02

Tags for this article:

Click the tags to see associated articles and topics

First-in-class pan-KRAS inhibitor shows strong antitumor activity in preclinical models. View article details on hiswai:

Excerpt

Media Specialist Contact. Julie Nagy. 1-713-563-3437 · JENagy@MDAnderson.org. MD Anderson Public Relations Office. 1-713-792-0655 · PublicRelations@ ...

Article found on: www.mdanderson.org

View Original Article